Logo image
Pipeline Embolization Device in the Treatment of Recurrent Previously Stented Cerebral Aneurysms
Journal article   Open access   Peer reviewed

Pipeline Embolization Device in the Treatment of Recurrent Previously Stented Cerebral Aneurysms

B Daou, R M Starke, N Chalouhi, S Tjoumakaris, D Hasan, J Khoury, R H Rosenwasser and P Jabbour
American journal of neuroradiology : AJNR, Vol.37(5), pp.849-855
05/2016
DOI: 10.3174/ajnr.A4613
PMID: 26611991
url
https://doi.org/10.3174/ajnr.A4613View
Published (Version of record) Open Access

Abstract

The use of the Pipeline Embolization Device in the management of recurrent previously stented cerebral aneurysms is controversial. The aim of this study was to evaluate the efficacy and safety of the Pipeline Embolization Device in the treatment of recurrent, previously stented aneurysms. Twenty-one patients with previously stented recurrent aneurysms who later underwent Pipeline Embolization Device placement (group 1) were retrospectively identified and compared with 63 patients who had treatment with the Pipeline Embolization Device with no prior stent placement (group 2). Occlusion at the latest follow-up angiogram, recurrence and retreatment rates, clinical outcome, complications, and morbidity and mortality observed after treatment with the Pipeline Embolization Device were analyzed. Patient characteristics were similar between the 2 groups. The mean time from stent placement to recurrence was 25 months. Pipeline Embolization Device treatment resulted in complete aneurysm occlusion in 55.6% of patients in group 1 versus 80.4% of patients in group 2 (P = .036). The retreatment rate in group 1 was 11.1% versus 7.1% in group 2 (P = .62). The rate of good clinical outcome at the latest follow-up in group 1 was 81% versus 93.2% in group 2 (P = .1). Complications were observed in 14.3% of patients in group 1 and 9.5% of patients in group 2 (P = .684). The use of the Pipeline Embolization Device in the management of previously stented aneurysms is less effective than the use of this device in nonstented aneurysms. Prior stent placement can worsen the safety and efficacy profile of this device.
Embolization, Therapeutic - instrumentation Recurrence Humans Middle Aged Male Treatment Outcome Embolization, Therapeutic - adverse effects Retreatment Cerebral Angiography Intracranial Aneurysm - therapy Adult Female Aged Retrospective Studies Stents

Details

Metrics

Logo image